Cortical bone microarchitecture assessed by μCT of the mid-diaphyseal femur from 8.5–9week old <i>Notch3</i>^{<i>em1Ecan</i>} mutant (gray bars) male mice and sex-matched l... by Ernesto Canalis (516050)

CD56⁺CD16⁺NK cells infiltration extent in different pathological type of lung cancer. by Shi Jin (641785)

CD56⁺CD16⁺ NK cell infiltration extent in different pathological type of lung cancer. by Shi Jin (641785)

(a) Tuberculosis (TB) incidence rate of 90 countries in 1990 and (b) TB mortality rate of 28 countries in 1950, according to the BCG vaccination status in 2015. by Kazuo Inoue (302545)

Normalized importance values (Mean Decrease Gini of Random Forest) of different category-wise features. by Md. Khaledur Rahman (4326274)

Treatment with mitochondrial shuttle inhibitors, GKA50, Ranolazine and glucose results in significant decreases in superoxide concentration as detected by coelenterazine chemilumin... by Laura L. Bronsart (844933)

IL-17A promotes OCP autophagy through the ERK/mTOR/Beclin1 pathway induced by RANKL. by Hao Tang (44155)

IL-17A promotes the expression of osteoclast-related genes involved in osteoclastogenesis. by Hao Tang (44155)

Effect of compound 16 on cell cycle progression in HCT-116 cells after 48h treatment. by Ahmed A. Gaber (13302308)

IL-17A inhibits apoptosis of OCPs. by Hao Tang (44155)

IL-17A promotes RANKL-stimulated osteoclastogenesis. by Hao Tang (44155)

Inhibition of autophagy attenuates IL-17A-mediated osteoclastogenesis. by Hao Tang (44155)

Mean plasma insulin concentration according to group during the maltodextrin tolerance test. by Mark Lown (3772432)

Mean plasma glucose concentrations according to group during the maltodextrin tolerance test. by Mark Lown (3772432)

Age-stage specific survival rate (<i>s</i>_<i>xj</i>) of <i>A</i>. <i>glycines</i>. by Aonan Zhang (8933630)

Age-stage-specific survival rate (<i>s</i>_<i>xj</i>) of <i>A</i>. <i>glycines</i>. by Aonan Zhang (8933630)

LRRK2 inhibition decreased IFN-γ–induced CD14, CD16 and MHC-II expression by monocytes. by Jonathan Thévenet (216051)

PARP-1 inhibition decreases atherogenic index in ApoE^−/− mice on HF diet for 16 weeks. by Chetan P. Hans (195965)

“…<p>Lipid profile data of 4 h starved mice shows that PARP-1 inhibition significantly increased HDL-cholesterol and total cholesterol in ApoE^−/− mice on regular diet (4A and 4C). After feeding HF diet for 16 weeks, total and LDL-cholesterol increased dramatically in ApoE^−/− mice. …”

Supplementary Material for: Decreased Systemic Levels of Endocan-1 and CXCL16 in Psoriasis Are Restored following Narrowband UVB Treatment by Sigurdardottir G. (5710955)

“…<b><i>Methods:</i></b> The levels of 17 potential biomarkers with an association with cardiovascular risk were quantitated in plasma from 37 age- and gender-matched psoriasis patients and controls at baseline and in 21 psoriasis patients after 12 weeks of NB-UVB treatment to identify a systemic treatment response. <b><i>Results:</i></b> We identified the mediators endocan-1, CXCL16, and sVEGFR1, which were systemically decreased in psoriasis at baseline, as well as FABP3, FABP4, and sIL-1R1, which showed normal baseline levels. …”

Glucose inhibition decreases IL-1β levels and tumor progression in the B16F10 mouse model. by Yunseo Woo (6157307)